CF
AMED

Corebridge Financial’s Amedisys AMED Stock Holding History

Corebridge Financial’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,171
Closed -$3.35M – 147
2025
Q1 		$3.35M Sell
36,171
-883
-2% -$81.4K 0.02% 811
2024
Q4 		$3.36M Sell
37,054
-1,532
-4% -$141K 0.02% 833
2024
Q3 		$3.72M Sell
38,586
-2,685
-7% -$262K 0.02% 830
2024
Q2 		$3.79M Buy
+41,271
New +$3.83M 0.02% 802

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Corebridge Financial's AMED Position: Q2 2025 in Review

Corebridge Financial sold out of Amedisys (AMED) in Q2 2025, closing a stake of 36,171 shares — an estimated $3.35M sold.

Corebridge Financial first reported a position in AMED in Q2 2024 and held it in 4 quarters. The position peaked at $3.79M in Q2 2024. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Corebridge Financial reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 36,171 Amedisys shares in Q2 2025, an estimated $3.35M.
  • Corebridge Financial first reported a position in Amedisys in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Amedisys position peaked at $3.79M in Q2 2024.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.